- Home
- CTEV vs EBS Comparison
CTEV vs EBS Comparison
Compare CTEV & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTEV
- EBS
- Stock Information
- Founded
- CTEV 1980
- EBS 1998
- Country
- CTEV United States
- EBS United States
- Employees
- CTEV N/A
- EBS N/A
- Industry
- CTEV
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- CTEV
- EBS Health Care
- Exchange
- CTEV NYSE
- EBS Nasdaq
- Market Cap
- CTEV 371.3M
- EBS 393.9M
- IPO Year
- CTEV N/A
- EBS 2006
- Fundamental
- Price
- CTEV $21.83
- EBS $5.65
- Analyst Decision
- CTEV Hold
- EBS Strong Buy
- Analyst Count
- CTEV 1
- EBS 3
- Target Price
- CTEV $19.00
- EBS $14.33
- AVG Volume (30 Days)
- CTEV 53.5K
- EBS 1.1M
- Earning Date
- CTEV 05-08-2025
- EBS 05-07-2025
- Dividend Yield
- CTEV N/A
- EBS N/A
- EPS Growth
- CTEV N/A
- EBS N/A
- EPS
- CTEV N/A
- EBS N/A
- Revenue
- CTEV $927,446,000.00
- EBS $965,400,000.00
- Revenue This Year
- CTEV $2.18
- EBS N/A
- Revenue Next Year
- CTEV $3.04
- EBS $19.88
- P/E Ratio
- CTEV N/A
- EBS N/A
- Revenue Growth
- CTEV N/A
- EBS N/A
- 52 Week Low
- CTEV $4.80
- EBS $4.02
- 52 Week High
- CTEV $31.00
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- CTEV N/A
- EBS 55.12
- Support Level
- CTEV N/A
- EBS $4.71
- Resistance Level
- CTEV N/A
- EBS $6.70
- Average True Range (ATR)
- CTEV 0.00
- EBS 0.43
- MACD
- CTEV 0.00
- EBS 0.13
- Stochastic Oscillator
- CTEV 0.00
- EBS 53.33
About CTEV CLARITEV CORPORATION
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.